Silexion Therapeutics Statistics
NASDAQ: SLXNHealthcareBiotechnologyUSD
0.2349-0.0187 (-7.37%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Silexion Therapeutics by the numbers
Silexion Therapeutics has a market capitalization of $3.4 million based on 14.47M shares outstanding. With trailing EPS of $-27.21, Silexion Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 60.9% below its 50-day average and 97.2% below its 200-day average.
Average daily trading volume is 9.90M shares, or about $2.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SLXN valuation vs. peer median
| Metric | SLXN | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.40M | $3.35M | +1% |
| Avg. volume | 9.90M | 376.27K | +2530% |
Peer median across 8 companies: SXTP, HCWB, ONCO, XRTX, CMND, CVKD, APVO, KAPA.
Valuation
- Market cap
- $3.40M
- EPS (TTM)
- $-27.21
- Shares outstanding
- 14.47M
Price and trading
- Previous close
- 0.2536
- Open
- 0.246
- Day range
- 0.2225 – 0.2499
- 52-week range
- 0.222 – 40.70
- 50-day moving average
- 0.6015
- Beta
- —
- Volume
- 1.48M
- Average volume
- 9.90M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 7, 2025
Additional statistics
- Market Cap
- 3.40M
- Forward Pe
- -0.37
- Eps
- -27.21
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.70
- Week52 Low
- 0.22
- Avg Volume
- 9.90M
- Shares Outstanding
- 14.47M
- Ma50
- 0.60
- Ma200
- 8.38
- Earnings Date
- Aug 7, 2025
- Pct From52w High
- -99.42%
- Pct From52w Low
- 5.81%